www.biotechcortex.com/2026/08/prec...
#science #biotechnolgy #biotechcortex
@biotechcortex.bsky.social
@biotechcortex.bsky.social
@biotechstockdaily.bsky.socialA global Phase 2 trial is testing TML-6, an investigational oral therapy for early Alzheimer's disease that targets the brain's own protein-clearing machinery rather than amyloid plaque directly.
#Alzheimers #Biotech #Biotechnolgy
Disclaimer: This is NOT a financial advice.